General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Karmiris K et al. – Introduction of adalimumab after failure of infliximab therapy resulted in a sustained clinical benefit in two thirds of patients during a median follow–up period of almost 2 years. Discontinuation was directly related to low adalimumab trough serum concentration, which was observed more frequently in patients who developed antibodies against adalimumab.


Related Articles

A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09    Relevance Score: 69%

Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09    Relevance Score: 69%

Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohns disease
Inflammatory Bowel Disease, 11/05/09    Relevance Score: 69%

C-Reactive Protein and Disease Activity in Children with Crohns Disease
Digestive Diseases and Sciences, 10/26/09    Relevance Score: 69%

Malignant Transformation in Perianal Fistulas of Crohns Disease: a Systematic Review of Literature
Journal of Gastrointestinal Surgery, 10/21/09    Relevance Score: 69%

Today in Clinical Pharmacology...keeping you current

Omeprazole induces gastric transmucosal permeability to the peptide bradykinin
World Journal of Gastroenterology, 03/10/10

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
Vascular Health and Risk Management, 03/10/10

A comparison of methadone, buprenorphine and alpha2 adrenergic agonists for opioid detoxification: A mixed treatment comparison meta-analysis
Drug and Alcohol Dependence, 03/10/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address